Ohio State Navbar

NCI Renews Support for Major Thyroid-Cancer Research Effort at Ohio State


The National Cancer Institute (NCI) has awarded a five-year, $11.3 million grant to a team of researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) to further their studies on thyroid cancer.

Principal investigator Matthew D. Ringel, MD, professor of medicine and a member of the OSUCCC – James Molecular Biology and Cancer Genetics (MBCG) Program, leads the NCI Program Project Grant (CA124570). The new grant is a continuation of a study that ran from 2008 through 2013 entitled “Genetic and Signaling Pathways in Epithelial Thyroid Cancer.”

For more information click on the link.

http://cancer.osu.edu/mediaroom/releases/Pages/NCI-Renews-Support-for-Major-Thyroid-Cancer-Research-Effort.aspx